526 related articles for article (PubMed ID: 7990646)
1. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Zadina JE; Kastin AJ; Ge LJ; Hackler L
Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
Erchegyi J; Kastin AJ; Zadina JE
Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
[TBL] [Abstract][Full Text] [Related]
3. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
[TBL] [Abstract][Full Text] [Related]
5. Interactions of Tyr-MIF-1 at opiate receptor sites.
Zadina JE; Kastin AJ
Pharmacol Biochem Behav; 1986 Dec; 25(6):1303-5. PubMed ID: 2880352
[TBL] [Abstract][Full Text] [Related]
6. A potent and selective endogenous agonist for the mu-opiate receptor.
Zadina JE; Hackler L; Ge LJ; Kastin AJ
Nature; 1997 Apr; 386(6624):499-502. PubMed ID: 9087409
[TBL] [Abstract][Full Text] [Related]
7. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
Zadina JE; Kastin AJ; Kersh D; Wyatt A
Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
[TBL] [Abstract][Full Text] [Related]
8. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2).
Hackler L; Kastin AJ; Zadina JE
Peptides; 1994; 15(6):945-50. PubMed ID: 7991457
[TBL] [Abstract][Full Text] [Related]
10. Hemorphins, cytochrophins, and human beta-casomorphins bind to antiopiate (TYR-MIE-1) as well as opiate binding sites in rat brain.
Zadina JE; Kastin AJ; Ge LJ; Brantl V
Life Sci; 1990; 47(8):PL25-30. PubMed ID: 1976197
[TBL] [Abstract][Full Text] [Related]
11. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
12. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
13. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes.
Harrison LM; Kastin AJ; Zadina JE
Peptides; 1998; 19(4):749-53. PubMed ID: 9622031
[TBL] [Abstract][Full Text] [Related]
15. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors.
Raffa RB; Kim A; Rice KC; de Costa BR; Codd EE; Rothman RB
Peptides; 1994; 15(3):401-4. PubMed ID: 7937312
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
17. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
18. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
[TBL] [Abstract][Full Text] [Related]
19. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
20. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
